Literature DB >> 30971418

Drug overdose deaths at work, 2011-2016.

Hope M Tiesman1, Srinivas Konda2, Lauren Cimineri3, Dawn N Castillo2.   

Abstract

Drug overdose fatalities have risen sharply and the impact on US workplaces has not been described. This paper describes US workplace overdose deaths between 2011 and 2016. Drug overdose deaths were identified from the Census of Fatal Occupational Injuries and fatality rates calculated using denominators from the Current Population Survey. Fatality rates were compared among demographic groups and industries. Negative binomial regression was used to analyse trends. Between 2011 and 2016, 760 workplace drug overdoses occurred for a fatality rate of 0.9 per 1 000 000 full-time equivalents (FTEs). Workplace overdose fatality rates significantly increased 24% annually. Workplace overdose fatality rates were highest in transportation and mining industries (3.0 and 2.6 per 1 000 000 FTEs, respectively). One-third of workplace overdose fatalities occurred in workplaces with fewer than 10 employees. Heroin was the single most frequent drug documented in workplace overdose deaths (17%). Workplace overdose deaths were low, but increased considerably over the six-year period. Workplaces are impacted by the national opioid overdose epidemic. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  overdoses; surveillance; workplace

Mesh:

Substances:

Year:  2019        PMID: 30971418      PMCID: PMC9187154          DOI: 10.1136/injuryprev-2018-043104

Source DB:  PubMed          Journal:  Inj Prev        ISSN: 1353-8047            Impact factor:   3.770


  8 in total

1.  Detection of drug abuse by health professionals.

Authors:  James E Meeker; Aaron M Mount; Wayne Ross
Journal:  Occup Health Saf       Date:  2002-08

2.  Drug Overdose Deaths in the United States, 1999-2016.

Authors:  Holly Hedegaard; Margaret Warner; Arialdi M Miniño
Journal:  NCHS Data Brief       Date:  2017-12

3.  Prescription for a hazardous workplace.

Authors:  Andrew Powell
Journal:  Occup Health Saf       Date:  2013-09

4.  Opioid Crisis: No Easy Fix to Its Social and Economic Determinants.

Authors:  Nabarun Dasgupta; Leo Beletsky; Daniel Ciccarone
Journal:  Am J Public Health       Date:  2017-12-21       Impact factor: 9.308

Review 5.  How effective is drug testing as a workplace safety strategy? A systematic review of the evidence.

Authors:  Ken Pidd; Ann M Roche
Journal:  Accid Anal Prev       Date:  2014-06-09

Review 6.  Characterizing the Interrelationships of Prescription Opioid and Benzodiazepine Drugs With Worker Health and Workplace Hazards.

Authors:  Michele Kowalski-McGraw; Judith Green-McKenzie; Sudha P Pandalai; Paul A Schulte
Journal:  J Occup Environ Med       Date:  2017-11       Impact factor: 2.162

7.  Drug-caused deaths in Australian medical practitioners and health-care professionals.

Authors:  Jennifer L Pilgrim; Rhyse Dorward; Olaf H Drummer
Journal:  Addiction       Date:  2016-11-20       Impact factor: 6.526

8.  Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region - United States, 2006-2015.

Authors:  Julie K O'Donnell; R Matthew Gladden; Puja Seth
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-09-01       Impact factor: 17.586

  8 in total
  3 in total

1.  Prescription opioid overdose and adverse effect hospitalisations among injured workers in eight states (2010-2014).

Authors:  Jeanne M Sears; Sheilah Hogg-Johnson; Ryan A Sterling; Deborah Fulton-Kehoe; Gary M Franklin
Journal:  Occup Environ Med       Date:  2020-04-10       Impact factor: 4.402

2.  Changes in drug poisoning mortality before and after the COVID-19 pandemic by occupation in Massachusetts.

Authors:  Devan Hawkins; Anh Tuan Phan
Journal:  Am J Ind Med       Date:  2022-05-16       Impact factor: 3.079

3.  Persistent and emerging hazards contributing to work-related fatalities in Alaska.

Authors:  Devin Lucas; Elizabeth Fitzgerald; Samantha Case; Mary O'Connor; Laura Syron
Journal:  Am J Ind Med       Date:  2020-06-01       Impact factor: 3.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.